News
Team
Projects
First Cohort
Second Cohort
Publications
Resources
Events
RTG-Events
Courses
Jobs
Contact
triple wild type
Shortened progression free and overall survival to immune-checkpoint inhibitors in BRAF-, RAS- and NF1- (“Triple”) wild type melanomas
Background Melanomas lacking mutations in BRAF, NRAS and NF1 are frequently referred to as “triple wild-type” (tWT) melanomas. They …
Philipp Jansen
,
Wolfgang Galetzka
,
Georg C. Lodde
,
Fabian Standl
,
Anne Zaremba
,
Rudolf Herbst
,
Patrick Terheyden
,
Jochen Utikal
,
Claudia Pföhler
,
Jens Ulrich
,
Alexander Kreuter
,
Peter Mohr
,
Ralf Gutzmer
,
Friedegund Meier
,
Edgar Dippel
,
Michael Weichenthal
,
Jan-Malte Placke
,
Jennifer Landsberg
,
Inga Möller
,
Antje Sucker
,
Annette Paschen
,
Eva Hadaschik
,
Lisa Zimmer
,
Elisabeth Livingstone
,
Dirk Schadendorf
,
Selma Ugurel
,
Andreas Stang
,
Klaus Griewank
Cite
Doi
ScienceDirect
Cite
×